Posts With Tag neurology

Showing 1 - 2 of 2 Posts

Biogen Inc. Q1 2025 Financial Report: Revenue Growth Amid Restructuring Challenges

$BIIB

•

Form 10-Q

•

2025-05-01

Last updated: 5 days ago

Biogen Inc. Q1 2025 Financial Report: Revenue Growth Amid Restructuring Challenges

Explore Biogen's Q1 2025 financial results, showcasing $2.43B revenue growth, net income decline, and strategic restructuring for future profitability.

Biogen Inc biopharmaceuticals neurology research and development restructuring initiatives

VistaGen Therapeutics Q4 2024 Financial Analysis: Hold Recommendation Amid Challenges

$VTGN

•

Form 10-Q

•

2025-02-13

Last updated: 3 months ago

VistaGen Therapeutics Q4 2024 Financial Analysis: Hold Recommendation Amid Challenges

Explore VistaGen Therapeutics, Inc.'s Q4 2024 report, highlighting cash position, accumulated deficit, and strategic recommendations for investors amid ongoing operating losses.

VistaGen Therapeutics biopharmaceutical neurology clinical trials therapeutic development